Tag Archives: Mylan

Tibotec licenses Rilpivirine (non exclusive) to Matrix, Hetero and Aspen

[J&J Press release] [Yahoo Finance] [Mylan Press Release] Tibotec Pharmaceuticals today announced that it has granted multiple non-exclusive licenses to generic manufacturers including Hetero Drugs Limited, Matrix Laboratories Limited (a Mylan company) of India and Aspen Pharmacare of South Africa to … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , , | Leave a comment

Orion sued Mylan for Comtan® (Entacapone 200 MG) tab

Orion Corporation has filed a patent infringement lawsuit in the United States to enforce Orion’s U.S. patent No. 5,446,194 (Expiry: Oct 2013) covering Comtan® against Mylan Pharmaceuticals Inc. (Mylan). [Press Release from Orion] – Not in english [Complaint copy] Orion … Continue reading

Posted in Patent case | Tagged , , , | Leave a comment

CI & Patent News:26/11/2010

Pronova BioPharma receives Lovaza(TM) Paragraph IV Notice Letter from Apotex Inc (Press release) Impax Laboratories Confirms Patent Challenge Relating to SIMCOR® Extended-Release Tablets, 1000/20 mg (link) Paragraph IV litigation: 1) Merck & Co., Inc Vs Hetero Drugs & Invagen Pharmaceuticals (No … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , , , | Leave a comment

CI & Patent News: 20/11/2010

1) GlaxoSmithKline and Fiocruz extend innovative collaboration to research and develop new medicines for neglected tropical diseases (Press Release) … This new collaborative framework, builds on a long-standing relationship between Fiocruz and GlaxoSmithKline, established in 1985, to manufacture vaccines for public … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , | Leave a comment

Modafinil Cephalon Vs Orchid & Mylan (UK Case)

Yesterday high court of London has denied to grant interim injunction on Mylan marketing generic version of Modafinil (provigil) in UK. The final trial is pending on April 2011 (on expedite basis) (order) The Case was about whether Orchid’s API … Continue reading

Posted in Patent case | Tagged , , | Leave a comment